A curiosity driven sojourn, across disciplines in science, led to the discovery of a safe adjuvant hidden in a beta glucan giving hope to patients with muscular dystrophy; A story of ZeitenWende all along, blessed with good people, hopefully a modest contribution to humanity by connecting the dots.
Published in Scientific Reports, a nature portfolio journal 15 November 2023 Significant reduction of muscle f
Edogawa NICHE Prize 2020 lecture by Dr. John Craig Venter, geneticist and a pioneer in human genome research in Toronto
Dr John Craig Venter to deliver the lecture in UHN Ajmera Transplant Center in University of Toronto
Neu REFIX beta glucans improving Multiple Sclerosis patients’ gut microbiome awarded as the best poster
Nichi BRITE Beta glucans yileding clinically encouraging outcome in a trial was presented in the webinar that commemorated World Parkinsons Day held on the 10th April 2023
Neurology Live, a clinical neurologists focused media portal has published GN Corporation’s presentation at the MDA on the Clinical trial results of Neu REFIX in Duchenne Muscular Dystrophy
GN Corporation will present the results of preclinical and clinical studies with neu REFIX (N-163), one of its
NICHI BRITE (AFO-202), one of the NICHI GLUCAN brand products for overseas markets, has undergone clinical tri
Japanese scientists, research collaborators to Nichi-in Centre for Regenerative Medicine
Neu REFIX B-glucans improve Anti-aging Butyrate & gut microbiome
Manuscript published in Stem Cell Reviews and Reports
